{"id":7786,"date":"2021-07-21T09:55:12","date_gmt":"2021-07-21T07:55:12","guid":{"rendered":"https:\/\/www.iqac.csic.es\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/"},"modified":"2026-06-16T11:11:13","modified_gmt":"2026-06-16T09:11:13","slug":"a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack","status":"publish","type":"post","link":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/","title":{"rendered":"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack"},"content":{"rendered":"<p>The <em>PhotoHeart<\/em> project is one of those selected in the CaixaResearch call, and will be funded with <strong>one million euros<\/strong> to develop a <strong>photopharmacological therapy that helps reduce heart damage after suffering a myocardial infarction<\/strong>. The project is led by <strong>Dr. Amadeu Llebaria<\/strong>, from the <a href=\"https:\/\/www.iqac.csic.es\/mcs\/\" target=\"_blank\" rel=\"noopener\"><strong>Medicinal Chemistry and Synthesis group (MCS)<\/strong><\/a>, accredited with the TECNIO seal, and will be developed in a consortium with <a href=\"http:\/\/es.vhir.org\/portal1\/homepage.asp?\" target=\"_blank\" rel=\"noopener\">La Vall d&#8217;Hebron Institut de Recerca<\/a> and<a href=\"https:\/\/www.jhu.edu\/\" target=\"_blank\" rel=\"noopener\"> The Hopkins University (United States)<\/a>.<\/p>\n<p><em>PhotoHeart <\/em>has been one of<a href=\"https:\/\/fundacionlacaixa.org\/es\/convocatoria-caixaresearch-investigacion-salud-proyectos-2021\" target=\"_blank\" rel=\"noopener\"> the 30 projects selected in the CaixaResearch call for Health Research 2021<\/a>, of the \u201cla Caixa\u201d Foundation. These are biomedical and health research projects of excellence of research centers and universities in Spain and Portugal, which have been endowed with a total of 22.1 million euros to be developed over the next three years.<\/p>\n<p>Full information of this call on this <a href=\"https:\/\/fundacionlacaixa.org\/es\/convocatoria-caixaresearch-investigacion-salud-proyectos-2021\" target=\"_blank\" rel=\"noopener\">LINK<\/a>.<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: right;\"><strong>IQAC-CSIC Communication<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The PhotoHeart project is one of those selected in the CaixaResearch call, and will be funded with one million euros to develop a photopharmacological therapy that helps reduce heart damage after suffering a myocardial infarction. The project is led by Dr. Amadeu Llebaria, from the Medicinal Chemistry and Synthesis group (MCS), accredited with the TECNIO<a class=\"more-link\" href=\"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/\">Continue reading <span class=\"screen-reader-text\">&#8220;A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack&#8221;<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":3726,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-7786","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\" \/>\n<meta property=\"og:description\" content=\"The PhotoHeart project is one of those selected in the CaixaResearch call, and will be funded with one million euros to develop a photopharmacological therapy that helps reduce heart damage after suffering a myocardial infarction. The project is led by Dr. Amadeu Llebaria, from the Medicinal Chemistry and Synthesis group (MCS), accredited with the TECNIOContinue reading &quot;A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/\" \/>\n<meta property=\"og:site_name\" content=\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/iqac.csic.es\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-21T07:55:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-16T09:11:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/IMG_2220-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ana Sotres\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IQAC_CSIC\" \/>\n<meta name=\"twitter:site\" content=\"@IQAC_CSIC\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ana Sotres\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/\"},\"author\":{\"name\":\"Ana Sotres\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/person\\\/ac65d00561d3a6d2810128c46771aff7\"},\"headline\":\"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack\",\"datePublished\":\"2021-07-21T07:55:12+00:00\",\"dateModified\":\"2026-06-16T09:11:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/\"},\"wordCount\":157,\"publisher\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/IMG_2220-scaled.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/\",\"name\":\"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/IMG_2220-scaled.jpg\",\"datePublished\":\"2021-07-21T07:55:12+00:00\",\"dateModified\":\"2026-06-16T09:11:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/IMG_2220-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/IMG_2220-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#website\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/\",\"name\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"description\":\"Chemistry for a better life\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#organization\"},\"alternateName\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.iqac.csic.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#organization\",\"name\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"alternateName\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/cropped-favicon-1.png\",\"contentUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/cropped-favicon-1.png\",\"width\":512,\"height\":512,\"caption\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\"},\"image\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/iqac.csic.es\\\/\",\"https:\\\/\\\/x.com\\\/IQAC_CSIC\",\"https:\\\/\\\/www.instagram.com\\\/iqac_csic\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC1JXTOe3-s8UnYu_A6-SI3A\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/iqac-csic\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/person\\\/ac65d00561d3a6d2810128c46771aff7\",\"name\":\"Ana Sotres\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g\",\"caption\":\"Ana Sotres\"},\"sameAs\":[\"https:\\\/\\\/www.iqac.csic.es\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/","og_locale":"en_US","og_type":"article","og_title":"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","og_description":"The PhotoHeart project is one of those selected in the CaixaResearch call, and will be funded with one million euros to develop a photopharmacological therapy that helps reduce heart damage after suffering a myocardial infarction. The project is led by Dr. Amadeu Llebaria, from the Medicinal Chemistry and Synthesis group (MCS), accredited with the TECNIOContinue reading \"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack\"","og_url":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/","og_site_name":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","article_publisher":"https:\/\/www.facebook.com\/iqac.csic.es\/","article_published_time":"2021-07-21T07:55:12+00:00","article_modified_time":"2026-06-16T09:11:13+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/IMG_2220-scaled.jpg","type":"image\/jpeg"}],"author":"Ana Sotres","twitter_card":"summary_large_image","twitter_creator":"@IQAC_CSIC","twitter_site":"@IQAC_CSIC","twitter_misc":{"Written by":"Ana Sotres","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/#article","isPartOf":{"@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/"},"author":{"name":"Ana Sotres","@id":"https:\/\/www.iqac.csic.es\/#\/schema\/person\/ac65d00561d3a6d2810128c46771aff7"},"headline":"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack","datePublished":"2021-07-21T07:55:12+00:00","dateModified":"2026-06-16T09:11:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/"},"wordCount":157,"publisher":{"@id":"https:\/\/www.iqac.csic.es\/#organization"},"image":{"@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/#primaryimage"},"thumbnailUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/IMG_2220-scaled.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/","url":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/","name":"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","isPartOf":{"@id":"https:\/\/www.iqac.csic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/#primaryimage"},"image":{"@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/#primaryimage"},"thumbnailUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/IMG_2220-scaled.jpg","datePublished":"2021-07-21T07:55:12+00:00","dateModified":"2026-06-16T09:11:13+00:00","breadcrumb":{"@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/#primaryimage","url":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/IMG_2220-scaled.jpg","contentUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/IMG_2220-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/www.iqac.csic.es\/en\/a-pioneering-project-proposes-light-controlled-drugs-to-reduce-heart-damage-after-a-heart-attack\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.iqac.csic.es\/en\/home\/"},{"@type":"ListItem","position":2,"name":"A pioneering project proposes light-controlled drugs to reduce heart damage after a heart attack"}]},{"@type":"WebSite","@id":"https:\/\/www.iqac.csic.es\/#website","url":"https:\/\/www.iqac.csic.es\/","name":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","description":"Chemistry for a better life","publisher":{"@id":"https:\/\/www.iqac.csic.es\/#organization"},"alternateName":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.iqac.csic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.iqac.csic.es\/#organization","name":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","alternateName":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","url":"https:\/\/www.iqac.csic.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.iqac.csic.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2025\/11\/cropped-favicon-1.png","contentUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2025\/11\/cropped-favicon-1.png","width":512,"height":512,"caption":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC"},"image":{"@id":"https:\/\/www.iqac.csic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/iqac.csic.es\/","https:\/\/x.com\/IQAC_CSIC","https:\/\/www.instagram.com\/iqac_csic","https:\/\/www.youtube.com\/channel\/UC1JXTOe3-s8UnYu_A6-SI3A","https:\/\/www.linkedin.com\/company\/iqac-csic\/"]},{"@type":"Person","@id":"https:\/\/www.iqac.csic.es\/#\/schema\/person\/ac65d00561d3a6d2810128c46771aff7","name":"Ana Sotres","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g","caption":"Ana Sotres"},"sameAs":["https:\/\/www.iqac.csic.es\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts\/7786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/comments?post=7786"}],"version-history":[{"count":1,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts\/7786\/revisions"}],"predecessor-version":[{"id":8618,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts\/7786\/revisions\/8618"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/media\/3726"}],"wp:attachment":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/media?parent=7786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/categories?post=7786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/tags?post=7786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}